Corbus Pharmaceuticals Holdings, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $8.9M | $15.0M |
| FY2017 | — | $57.8M | $62.5M |
| FY2018 | — | $27.5M | $41.7M |
| FY2019 | — | $6.2M | $31.7M |
| FY2020 | $18.0M | $45.3M | $85.4M |
| FY2021 | $15.6M | $69.1M | $25.0M |
| FY2022 | $16.0M | $33.0M | $17.0M |
| FY2023 | $0 | $-6.9M | $13.7M |
| FY2024 | — | $142.4M | $17.2M |
| FY2025 | — | $147.5M | $28.5M |